Butyrylcholinesterase interactions with amylin may protect pancreatic cells in metabolic syndrome

The metabolic syndrome (MetS) is a risk factor for type 2 diabetes mellitus (T2DM). However, the mechanisms underlying the transition from MetS to T2DM are unknown. Our goal was to study the potential contribution of butyrylcholinesterase (BChE) to this process. We first determined the hydrolytic ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Shenhar-Tsarfaty, Shani, Bruck, Tal, Bennett, Estelle R, Bravman, Tsafrir, Aassayag, Einor Ben, Waiskopf, Nir, Rogowski, Ori, Bornstein, Natan, Berliner, Shlomo, Soreq, Hermona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2011
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373355/
https://www.ncbi.nlm.nih.gov/pubmed/20807286
http://dx.doi.org/10.1111/j.1582-4934.2010.01165.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373355/
https://www.ncbi.nlm.nih.gov/pubmed/20807286
http://dx.doi.org/10.1111/j.1582-4934.2010.01165.x

Ejemplares similares